back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-03-07 11:29 Tx date 2025-01-03 |
$CSCI
COSCIENS Biopharma Inc. (formerly Aeterna Zentaris Inc.) |
Gagnon, Gilles
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-1,416 vol |
12,980 | |
| Filed 2025-03-07 11:28 Tx date 2025-01-02 |
$CSCI
COSCIENS Biopharma Inc. (formerly Aeterna Zentaris Inc.) |
Gagnon, Gilles
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-3,540 vol |
14,396 | |
| Filed 2024-06-07 15:22 Tx date 2024-06-03 |
$AEZS
Aeterna Zentaris Inc. |
Gagnon, Gilles
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+17,936 vol |
17,936 | |
| Filed 2024-06-07 15:22 Tx date 2020-01-01 |
$AEZS
Aeterna Zentaris Inc. |
Gagnon, Gilles
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-06-07 15:22 Tx date 2024-06-03 |
$AEZS
Aeterna Zentaris Inc. |
Gagnon, Gilles
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Prodev Pharma Inc. (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+5,900 vol |
5,900 | |
| Filed 2024-06-07 15:21 Tx date 2020-01-01 |
$AEZS
Aeterna Zentaris Inc. |
Gagnon, Gilles
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Prodev Pharma Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-06-07 15:20 Tx date 2024-06-03 |
$AEZS
Aeterna Zentaris Inc. |
Gagnon, Gilles
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+36,062 vol |
36,062 | |
| Filed 2024-06-07 15:20 Tx date 2020-01-01 |
$AEZS
Aeterna Zentaris Inc. |
Gagnon, Gilles
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-06-07 15:16 Tx date 2024-06-03 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-700,000 vol |
0 | |
| Filed 2024-06-07 15:15 Tx date 2024-06-03 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Holder: Prodev Pharma Inc. (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-250,000 vol |
0 | |
| Filed 2024-06-07 15:15 Tx date 2024-06-03 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-1,489,000 vol |
0 | |
| Filed 2024-06-05 18:31 Tx date 2024-05-03 |
$AEZS
Aeterna Zentaris Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
37 - Stock split or consolidation
|
-36,750 vol |
12,250 | |
| Filed 2024-01-10 15:57 Tx date 2024-01-04 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-23,100
-60,000 vol $0.385 each |
700,000 | |
| Filed 2023-06-14 16:13 Tx date 2023-06-14 |
$AEZS
AEterna Zentaris Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+25,000 vol |
49,000 | |
| Filed 2023-01-05 16:58 Tx date 2023-01-03 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$93,000
+150,000 vol $0.62 each |
760,000 | |
| Filed 2022-08-08 17:18 Tx date 2022-08-03 |
$AEZS
AEterna Zentaris Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+20,000 vol |
24,000 | |
| Filed 2022-08-08 17:18 Tx date 2022-07-21 |
$AEZS
AEterna Zentaris Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
37 - Stock split or consolidation
|
-96,000 vol |
4,000 | |
| Filed 2022-07-19 14:46 Tx date 2022-07-15 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-15,000
-150,000 vol $0.10 each |
610,000 | |
| Filed 2022-07-19 14:38 Tx date 2022-07-15 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$15,000
+150,000 vol $0.10 each |
1,489,000 | |
| Filed 2021-05-20 22:48 Tx date 2021-05-19 |
$AEZS
AEterna Zentaris Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+70,000 vol |
100,000 |